Search

Search Constraints

You searched for: Author/Creator Sandner, Peter

Search Results

5. Benign prostatic hyperplasia/obstruction ameliorated using a soluble guanylate cyclase activator. Issue 4 (15th February 2022)

6. Novel soluble guanylyl cyclase activators increase glomerular cGMP, induce vasodilation and improve blood flow in the murine kidney. (3rd July 2021)

7. Additive effects of the Rho kinase inhibitor Y‐27632 and vardenafil on relaxation of the corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure. (21st November 2016)

10. Soluble guanylate cyclase activator BAY 54–6544 improves vasomotor function and survival in an accelerated ageing mouse model. Issue 9 (27th August 2022)